European Medicines Agency
Buying intent
19 tracked signals | Top 15 topics are below.
Attention by team
LinkedIn activity, by teamWhere European Medicines Agency's own people are actually spending their attention, by team, by topic. Bands run Low to High against the busiest pairing on this page, and each cell also shows how much of that team's own activity it represents.
Topics being researched
30-day windowEvery tracked topic, ranked by volume, not by our guess at what matters. Confidence is the classifier's own certainty that a signal belongs where we've filed it.
29d ago
29d ago
16d ago
9d ago
15d ago
16d ago
4d ago
29d ago
9d ago
4d ago
29d ago
15d ago
29d ago
22d ago
16d ago
Need intent for a specific topic or industry?
We track the full taxonomy across every account in the graph — including themes not shown on this page.
Who's active at European Medicines Agency
verified title on fileTitles, seniority and topic straight from each person's own activity, with a LinkedIn link so you can check any of them yourself.
Primary products / business lines
LinkedIn company profileThe European Medicines Agency (EMA) is a decentralised body of the European Union with headquarters in Amsterdam. Its main responsibility is the protection and promotion of public and animal health, through the evaluation and supervision of medicines for human and veterinary use.
Top accounts researching European Medicines Agency
names withheld on the public pageThese are companies whose own people brought up European Medicines Agency unprompted, not accounts we guessed might be interested. We can't yet tell an implementation partner from a genuine buyer here, names unlock along with the buyer profile below.
343 companies · 974 people are researching Software system test and evaluation process
European Medicines Agency's own team shows 1 signal on this topic. No one outside European Medicines Agency has been seen researching the company by name yet — so this is the market it sits in, not a list of its buyers.
- High-impact system5,974 cos · 17,680 people
- Global pricing management42 cos · 108 people
Buyer profile
company size · seniorityCompany size and how senior the people involved are, the two things that decide whether this is a real deal. Competitor overlap isn't computed yet for this account.
What's been said
public posts mentioning European Medicines AgencyUp to 9 public excerpts naming European Medicines Agency from the past 365 days, across LinkedIn, Reddit, X, YouTube and other public sources.
This #WorldVeterinaryDay , I want to recognise the vital contribution veterinarians make every day to animal health and welfare, to food safety, and to public health across Europe and beyond. Veterinarians are often the first line of defence against animal disease. Whether on farms, in clinics, in laboratories, or elsewhere in the field. Through their work, they safeguard not only the wellbeing of animals, but also the confidence consumers place in the food on their plates. This connection between animal and human health is at the heart of the One Health approach. At the European Medicines Agency , veterinary medicine is a core part of our public health mission. Alongside our partners across the EU, we work to ensure veterinary medicines are effective, safe and responsibly used. Supporting veterinarians in their work and helping to protect society as a whole. One important – though sometimes less visible – part of this work is EMA’s role in recommending maximum residue limits (MRLs) for veterinary medicines used in food-producing animals. When veterinary medicines are used in animals raised for food, its essential to ensure that any residue remaining in meat, milk and eggs are at levels that are safe for consumers. MRLs define the highest level of residue legally permitted in food. In order to establish MRLs, EMA’s Committee for Veterinary Medicinal Products, together with scientific experts from across the EU, evaluates data on how medicines are absorbed, distributed and eliminated from animals. Veterinarians play a vital role in this process by prescribing or administering authorised medicines in accordance with product information, respecting the dose and the withdrawal period. This ensures that residues in food remain below the established MRL, and thus food of animal origin on the market remains safe, compliant, and fit for consumption. This process is a clear example of how science, regulation and veterinary practice come together in the public interest. It supports food safety, underpins trust in the EU regulatory system, and helps ensure that veterinary medicines can continue to be used responsibly where they are needed. Today, veterinary professionals face complex and evolving challenges, from emerging animal diseases and antimicrobial resistance to sustainability and climate pressures. Regulation must evolve alongside these realities. At EMA, our work is ultimately about enabling veterinarians to do what they do best: make informed clinical decisions, protect animal health and welfare, and act as partners in safeguarding public health. To all veterinarians across Europe and around the world, thank you for your commitment, expertise and dedication.
Apr 2026